Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iCHF-2: Intravenous Iron in Cardiovascular Disease and Iron Deficiency
NCT03991000Phase 3Terminated
- Start
- Feb 2019
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
A Phase 3 trial of ferric carboxymaltose in iron deficiency anemia (IDA). Started Feb 2019; status: terminated.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03991000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03991000.